NSE: LUPIN | BSE: 500257

Mid-range Performer

Download real time

2061.65 27.00 (1.33%)

38.06% Gain from 52W Low

266.2K NSE+BSE Volume

NSE 19 Mar, 2025 3:06 PM (IST)

94,122.8

Market Cap

High in industry

0.6

Beta 1Year

Very Low volatility

US FDA Approval

Lupin gets US FDA tentative approval for Amifampridine tablets, with a market size of $306 million See details

Lupin Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for LUPIN, BSE:500257 Lupin Ltd.

Is Lupin Ltd. worth buying?

907 Votes:

Buy 72.66%

Sell 17.64%

Hold 9.7%

RESEARCH REPORTS

Hold SEE REPORTS >

Buy SEE REPORTS >